Tag: Bilinta
Brilinta fails to demonstrate benefit over clopidogrel for peripheral artery disease...
AstraZeneca has announced that top-line results from the EUCLID trial indicate that Brilinta (ticagrelor) did not demonstrate a benefit over clopidogrel in a symptomatic...